The Harvard Medical School Diabetes Update
Diabetes Update will be held online this year, using live streaming, electronic Q&A, and other remote learning technologies.Â
EDUCATION to MEET THE CHALLENGES of DIABETES CARE
At a time when our diabetes knowledge and treatment options have advanced so much, why do clinical outcomes remain suboptimal, with so many patients unable to achieve good control of their disease?
The answer is rooted in four challenges:
Keeping pace with rapidly advancing clinical options for diabetes care:
Therapies
Technologies
Lifestyle medicine interventions
Designing comprehensive therapeutic interventions based on frequent diabetes-associated diseases and complications
Accounting for a patient’s unique biological, psychological, social, financial, educational, and cultural factors
Overcoming structural health care barriers that require clinical strategies to fit within a particular mold
This course is designed to equip clinicians to meet these challenges, providing practical, evidence-based approaches to optimize care for your patients.
STRATEGIES, UPDATES, and BEST PRACTICES for STATE-OF-THE-ART DIABETES CARE
This program affords you the opportunity to learn from leaders in the field of diabetes who are distinguished for their outstanding teaching, knowledge, and innovations in clinical care.
Participants can rely on this program for comprehensive education to ensure state-of-the-art treatment. Coverage includes:
Designing more effective treatment plans
Current anti-diabetes medications and how to use them
Diagnosis of different types of diabetes
Utilization of recent technology advances in diabetes care
Optimizing care for people with obesity
Assessing and treating cardiovascular and renal complications
Guiding patients on physical activity and medical nutrition
Management of hypertension and dyslipidemia
Addressing low engagement in therapy
NEW DATA and PRACTICE GUIDELINES for DIABETES CARE
The newest data on the identification of different types of diabetes
The latest scientific information on how to reduce cardiovascular and renal disease risk in patients with type 2 diabetes
New guidelines and practice recommendations for nutrition and physical activity coupled with instruction to incorporate them into your current approaches to diabetes care
Criteria to navigate the controversial data related to some anti-diabetes medications
Medical vs. surgical management of obesity
New technologies in diabetes care: updates and implications for day-to-day care
Research breakthroughs
Tips and tricks for navigating barriers within health care systems
ASSESSMENT and TREATMENT of COMPLICATIONS from DIABETES
The 2025 program provides education to assess and treat:
Cardiovascular Disease
Congestive Heart Failure
Renal Disease
Metabolic-Associated Steatotic Liver Disease
OPTIMIZING HEALTH OUTCOMES for DIVERSE PATIENT POPULATIONS
This program also provides comprehensive guidance to account for biological, psychological, emotional, social, financial, and cultural factors that impact the development and progression of diabetes.
Coverage includes:
Racial and ethnic minorities
The elderly
People with obesity
Patients at high cardiovascular risk
Individuals with low engagement in therapy
Patients at low socio-economic levels
Subjects with low health literacy/education
Individuals with depression/emotional distress
Patients with metabolic liver disease
PRACTICE IMPACT
Over four days, you will gain new, encompassing, evidence-based approaches to address the challenges seen in most clinical practices. More importantly, you will leave with knowledge—part art, part science—to make a real difference in the lives of your patients.
OPTIMIZED for REMOTE EDUCATION
The 2025 program has been enhanced for distance learning. In addition to being live streamed, all sessions will be recorded and made available to participants for online viewing for 60 days after the end of the course.
Along with recordings and course presentations, additional resources such as guidelines, recent articles and relevant patient education materials will also be available.
Schedule
Tuesday, April 29, 2025
9:00am to 9:15am
Welcome and Introduction
Course Directors
Identifying Various Types of Diabetes in Clinical Practice
9:15am to 9:40am
Is It Type 1 Diabetes, Type 2 Diabetes, or Something Else?
Miriam Udler, MD, PhD
9:40am to 10:05am
The Connection Between Diabetes Phenotypes and Social Determinants of Health
Jacqueline Seiglie, MD
10:05am to 10:45am
Panel Discussion and Practical Recommendations
Miriam Udler, MD, PhD and Jacqueline Seiglie, MD
10:45am to 11:00am
Break
Medical Nutrition Management in Diabetes and Obesity
11:00am to 11:25am
Does When You Eat Matter? Intermittent Fasting, Circadian Rhythms, and Food Order
Courtney Peterson, PhD, MSc, MA, MS
11:25am to 11:50am
Current Dietary Recommendations in Diabetes and Obesity
Laura Andromalos, MS, RD, RN, CSOWM, CDCES
11:50am to 12:30pm
Panel Discussion and Practical Recommendations
Courtney Peterson, PhD, MSc, MA, MS and Laura Andromalos, MS, RD, RN, CSOWM, CDCES
12:30pm to 1:20pm
Break
Prescribing Exercise to Patients with Diabetes
1:20pm to 1:45pm
Exercise Recommendations in Type 2 Diabetes and Obesity
Edward M. Phillips, MD
1:45pm to 2:10pm
A Practical Exercise Session Demonstration
Jacqueline I. Shahar, MEd, RCEP, CDCES
2:10pm to 2:50pm
Panel Discussion and Practical Recommendations
Edward M. Phillips, MD and Jacqueline I. Shahar, MEd, RCEP, CDCES
2:50pm to 3:00pm
Break
Special Lecture
3:00pm to 3:45pm
Improving Diabetes Care by Addressing Patient, Health Care Professional, and Health Care System Factors
A. Enrique Caballero, MD
Wednesday, April 30, 2025
9:00am to 9:10am
Welcome, Recap, and Introduction to Day 2
Course Directors
Obesity Management in the Patient with Diabetes
9:10am to 9:40am
Health Implications of Overweight and Obesity: A Focus on Sleep Disorders
Peminda Cabandugama, MD, DABOM
9:40am to 10:10am
Lifestyle Modification in Obesity: Does It Work?
Julia Lloyd, MPH, RD, CDCES
10:10am to 10:50am
Pharmacological Management: What Intervention and When?
W. Scott Butsch, MD, MSc
10:50am to 11:05am
Break
11:05am to 11:35am
Surgical Management of Obesity: An Update
Matthew M. Hutter, MD, MBA, MPH
11:35am to 12:15pm
Panel Discussion and Practical Recommendations
W. Scott Butsch, MD, MSc, Matthew M. Hutter, MD, MBA, MPH, and Julia Lloyd, MPH, RD, CDCES
12:15pm to 1:05pm
Break
Management of Traditional CV Risk Factors in Diabetes
1:05pm to 1:45pm
Dyslipidemia Management in the Patient with Diabetes
Om P. Ganda, MD
1:45pm to 2:30pm
Hypertension Management in the Patient with Diabetes
Naomi D. Fisher, MD
2:30pm to 3:00pm
Q and A and Practical Recommendations
Om P. Ganda, MD and Naomi D. Fisher, MD
Special Lecture
3:00pm to 3:45pm
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A 2025 Vision
Kenneth Cusi, MD
Thursday, May 1, 2025
9:00am to 9:10am
Welcome, Recap, and Introduction to Day 3
Course Directors
Cardiovascular Disease in the Patient with Diabetes
9:10am to 9:40am
Coronary Artery Disease: Evaluation and Management
Jorge Plutzky, MD
9:40am to 10:10am
Heart Failure in the Patient with Diabetes: An Update
Deepak L. Bhatt, MD, MPH, MBA
10:10am to 10:45am
Q and A and Practical Recommendations
Jorge Plutzky, MD and Deepak L. Bhatt, MD, MPH, MBA
10:45am to 11:00am
Break
Renal Disease in the Patient with Diabetes
11:00am to 11:25am
Evaluation of Chronic Kidney Disease
Katherine R. Tuttle, MD
11:25am to 11:50am
Prevention and Management of Chronic Kidney Disease
Janani Rangaswami, MD, FACP, FCRS, FAHA
11:50am to 12:30pm
Q and A and Practical Recommendations
Katherine R. Tuttle, MD and Janani Rangaswami, MD, FACP, FCRS, FAHA
12:30pm to 1:20pm
Break
Technology Advances in Diabetes Care
1:20pm to 1:50pm
Continuous Glucose Monitoring: A 2025 Vision
Devin Steenkamp, MD
1:50pm to 2:20pm
Insulin Pumps, Closing the Loop: Where Do We Stand?
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP
2:20pm to 2:50pm
Q and A and Practical Recommendations
Devin Steenkamp, MD and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP
2:50pm to 3:00pm
Break
Special Lecture
3:00pm to 3:45pm
Artificial Intelligence in Diabetes Care: Fact or Fiction?
James Flory, MD
Friday, May 2, 2025
9:00am to 9:10am
Welcome, Recap, and Introduction to Day 4
Course Directors
Pharmacological Management of Type 2 Diabetes: Traditional Medications
9:10am to 9:50am
Traditional Medications (Biguanides, SUs, TZDs, Alpha-Glucosidase Inhibitors)
Deborah J. Wexler, MD, MPH
9:50am to 10:30am
Insulin Therapy in the Patient with Diabetes
Guillermo E. Umpierrez, MD, CDCES, FACE, MACP
10:30am to 11:10am
Q and A and Practical Recommendations
Deborah J. Wexler, MD, MPH and Guillermo E. Umpierrez, MD, CDCES, FACE, MACP
11:10am to 11:20am
Break
Special Lecture
11:20am to 12:00pm
Lack of Adherence to Therapy and Clinical Inertia: How to Overcome Them
Anne Peters, MD
12:00pm to 1:00pm
Break
Pharmacological Management of Type 2 Diabetes: Newer Medications
1:00pm to 1:35pm
SGLT-2 Inhibitors: An Update
Silvio E. Inzucchi, MD
1:35pm to 2:10pm
GLP-1 Receptor Agonists: An Update
Lee-Shing Chang, MD
2:10pm to 2:45pm
Mineralocorticoid Receptor Antagonists: Role in Diabetes Care
Romela Petrosyan, MD
2:45pm to 3:30pm
Q and A and Practical Recommendations
Silvio E. Inzucchi, MD, Lee-Shing Chang, MD, and Romela Petrosyan, MD
3:30pm to 3:40pm
Closing Remarks
Course Directors
